HOTH
NASDAQ · Pharmaceuticals
Hoth Therapeutics Inc
$1.01
-0.07 (-6.48%)
Open$1.06
Previous Close$1.08
Day High$1.10
Day Low$0.98
52W High$2.45
52W Low$0.49
Volume—
Avg Volume10.56M
Market Cap30.69M
P/E Ratio—
EPS$-0.81
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+157.4% upside
Current
$1.01
$1.01
Target
$2.60
$2.60
$1.73
$2.60 avg
$4.05
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |
| Rev Growth | +13.3% | +17.8% | +20.0% |
| Debt/Equity | 0.67 | 0.60 | 0.55 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |